Helicobacter pylori infection in gastric extranodal marginal zone lymphoma of mucosaassociated lymphoid tissue (MALT) lymphoma: A re-evaluation

Gut

Volumn 63, Issue 9, 2014, Pages 1526-1528

  Mendes, Larissa Sena Teixeira ^a   Attygalle, Ayoma D ^a   Wotherspoon, Andrew C ^a  

^a ROYAL MARSDEN HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; CANCER REGRESSION; CELL PROLIFERATION; CLINICAL EVALUATION; DISEASE ASSOCIATION; ERADICATION THERAPY; FEMALE; HELICOBACTER INFECTION; HUMAN; LARGE CELL LYMPHOMA; LYMPHOMA CELL; MAJOR CLINICAL STUDY; MALE; MARGINAL ZONE LYMPHOMA; NOTE; PRIORITY JOURNAL; STOMACH LYMPHOMA; TREND STUDY; TUMOR ASSOCIATED LEUKOCYTE;

GASTRIC LYMPHOMA; HELICOBACTER PYLORI - EPIDEMIOLOGY;

FEMALE; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; LYMPHOMA, B-CELL, MARGINAL ZONE; MALE; STOMACH NEOPLASMS;

EID: 84905465731     PISSN: 00175749     EISSN: 14683288     Source Type: Journal    
DOI: 10.1136/gutjnl-2014-307389     Document Type: Note

References (9)

1. Wotherspoon AC, Ortiz-Hidalgo C, Falzon MR, et al. Helicobacter pylori-associated gastritis and primary B-cell gastric lymphoma. Lancet 1991;338:1175-6.
2. Nakamura S, Sugiyama T, Matsumoto T, et al. Long-term clinical outcome of gastric MALT lymphoma after eradication of Helicobacter pylori: a multicentre cohort follow-up study of 420 patients in Japan. Gut 2012;61:507-13.
3. Ruskone-Fourmestraux A, Lavergne A, Aegerter PH, et al. Predictive factors for regression of gastric MALT lymphoma after Helicobacter pylori treatment. Gut 2001;48:297-303.
4. Asenjo LM, Gisbert JP. Prevalence of Helicobacter pylori infection in gastric MALT lymphoma: a systematic review. Rev Esp Enferm Dig 2007;99:398-404.
5. Luminari S, Cesaretti M, Marcheselli L, et al. Decreasing incidence of gastric MALT lymphomas in the era of anti-Helicobacter pylori interventions: results from a population-based study on extranodal marginal zone lymphomas. Ann Oncol 2009;21:855-9.
6. Gisbert JP, Aguado B, Luna M, et al. Gastric MALT lymphoma: clinical characteristics and prevalence of H. pylori infection in a series of 37 cases. Rev Esp Enferm Dig 2006;98:655-65.
7. Nakajima S, Nishyiama Y, Yamaoka M, et al. Changes in the prevalence of Helicobacter pylori infection and gastrointestinal diseases in the past 17 years. J Gastroenterol Hepatol 2010;25(Suppl 1):S99-S110.
8. Megraud F, Coenen S, Versporten A, et al. Helicobacter pylori resistance to antibiotics in Europe and its relationship to antibiotic consumption. Gut 2013;62:34-42.
9. Zullo A, Hassan C, Ridola L et al. Eradication therapy in Helicobacter pylori-negative, gastric low-grade mucosa-associated lymphoid tissue lymphoma patients: a systematic review. J Clin Gastroenterol 2013;47:824-7.